Dr. Marc Rohrbach, MD

Dr. Rohrbach practices at Confluence Health Hospital | Central Campus in Wenatchee, Washington, part of Confluence Health.

Dr. Rohrbach's NPI, 1801230743, was assigned on April 22, 2013. Dr. Rohrbach graduated from University of Washington School of Medicine in 2015. Dr. Rohrbach holds Washington license MD60852638.

Dr. Rohrbach's primary practice is Confluence Health Hospital | Central Campus, at 1201 S Miller Street, Wenatchee, WA 98807 in Chelan County. The practice phone is (509) 662-1511.

Dr. Rohrbach's primary practice is Confluence Health Hospital | Central Campus in Wenatchee, Washington, part of Confluence Health. Dr. Rohrbach is also affiliated with Mid Valley Hospital. The medical group on file is Confluence Health. Dmand AI also links Dr. Rohrbach to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohrbach practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rohrbach's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Rohrbach's licenses on file in 2 states: Washington and Wisconsin.

CMS data shows 620 Medicare services from Dr. Rohrbach across 10 procedure codes in 2024, for 271 Medicare patients. Medicare paid $27,500 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Rohrbach in 2024. The largest group is 75 to 84, with 107 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rohrbach's median patient age at 43, with 51% women.

In 2024, Dr. Rohrbach wrote 339 Medicare Part D claims for 123 patients. 95% of them were for generic drugs. CMS names the drug for 216 of them, across 9 drugs with 11 or more claims each, at $3,656 in total drug cost. In 2023, CMS named 300 claims across 13 drugs.

Dr. Rohrbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rohrbach as offering telehealth.

Dmand AI links 5 papers to Dr. Rohrbach, published from 2016 to 2017. 2016 was the busiest year, with 3. The most frequent topics are Oropharyngeal Neoplasms. Dr. Rohrbach's most frequent co-authors are Aaron Michael Wieland, MD, Christopher J. Britt, MD and Chad Michael Ennis, MD.

CMS Open Payments shows 4 general payments to Dr. Rohrbach from 3 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $61.

Dr. Rohrbach graduated from University of Washington School of Medicine in 2015.